US praises Korea’s Covid-19 diagnostic strategy

Recently, the US Food and Drug Administration (FDA) released the report ‘Korea’s Response to COVID-19’, which focused analysis on the development, approval, and use of related drugs. related to the Korean Government’s COVID-19 diagnostic test.
The report indicates that Korea’s strategy last April was successful in containing the wave of COVID-19 spread, and was recognized worldwide. The Korean experience can become useful information when considering future options. Therefore, the FDA has conducted a review of the information reported by the media and the information published by the Seoul Government about the strategy to deal with COVID-19.

Students in South Korea have returned to normal school with splash shields. (Photo: AP) However, the FDA also emphasized that each country’s approach may vary, so it does not recommend any approach to the United States to deal with new infectious diseases that will emerge. The above report introduces Korea’s approach to the COVID-19 epidemic, based on lessons learned from the Middle East Acute Respiratory Syndrome (MERS) outbreak in 2015, detailing the Korea’s efforts to deal with infectious diseases. The report indicates that the Seoul Government has invested heavily in the commercial use of infectious disease diagnostic technology, which has helped Korean private enterprises develop and rapidly produce testing equipment. In addition, South Korea followed the US, applying an “emergency use authorization” (EUA) regime for COVID-19 diagnosis. The Korean justice agency has revised the law, so that the authorities have the right to collect information about patients and people suspected of having infectious diseases in critical situations. Along with that, measures such as mandatory wearing of masks, social distancing, stopping some business activities, and effective exchange strategies, have helped South Korea contain the wave of COVID-19 spread. On the other hand, according to the ranking of resilience from the COVID-19 epidemic (Covid Resilience Ranking) published by Bloomberg (USA) every month, South Korea ranked 5th out of 53 assessed countries, an increase of one place compared to the previous year. with April. Korea’s highest ranking was 4th in November last year.